The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.
Global Rebalancing Will Lead to Global Prosperity European leaders and the media are up in arms over recent U.S. policy decisions to support the reshoring of American industry. The export ban on advanced U.S. semiconductor equipment, the tax credits for renewable energy equipment made in the U.S., and especially the support for American-made electric vehicles…
Key Points Steel imports from Mexico have surged over the past several years. U.S. steel imports from Mexico have risen by 141% over historic levels, with some subcategories of imports tripling and quadrupling, despite a 2019 U.S.-Mexico agreement to maintain steel imports at past levels. The surge in steel imports in Mexican steel conduit, used…
Can the U.S. really bring manufacturing home? A McKinsey study shows that existing concentration of some supply chains will make it hard. Here’s what needs to be done.
Arizona gets $60 million solar plant. But the owner is China’s JA Solar, a company that will be in the cross hairs of forced labor laws.
By Charles Benoit, CPA Trade Counsel In December, the U.S.-China Commission, a group created by Congress to advise on managing the bilateral relationship, formally recommended that China lose its Most-Favored Nation (MFN) tariff status. Referencing the decision to grant China permanent MFN status in 2001, Speaker McCarthy said in remarks on the House floor yesterday…
Canadian Solar is mostly Chinese-run and produced. Its solar panels in a Maine government project may be tainted by forced labor.
Key Points U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge. India and China are increasingly the leading U.S. source for generic pharmaceuticals, which account for 90% of all prescriptions written in the U.S. In 2021, China was the leading source for U.S. pharmaceutical…
A Department of Energy official warns that China’s outsized role in the solar industry is a headwind for Biden’s green energy plans, and energy security.
The November trade deficit fell, but that didn’t stop the U.S. from record imports this year. The goods deficit is now over $1.1 trillion.
